| Jul 29 |
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
|
| Jul 29 |
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
|
| Jul 29 |
Longeveron’s Phase IIa Alzheimer’s therapy trial meets efficacy endpoints
|
| Jul 28 |
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)
|
| Jul 27 |
Bullish Longeveron Insiders Loaded Up On US$734.3k Of Stock
|
| Jul 24 |
(LGVN) - Analyzing Longeveron's Short Interest
|
| Jul 19 |
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Jul 18 |
Longeveron slides on $9M stock offering
|
| Jul 18 |
Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Jul 17 |
Longeveron stock rallies 19% on Alzheimer's drug update
|
